Moderna raises 2026 outlook as CEO says newer vaccines are gaining traction
The biotech company now expects 2026 revenue growth of 15% to 25%, up from its previous guidance of up to 10%.
ImpactNotable
Published6 d ago (Fri, 06 Nov 2026 11:56:04 GMT)
MoreLess
Impact score35/100
RatingProbability of 66%.
RegionsGlobal
Retrievedvia rss
ClassifiedFri, 06 Nov 2026 12:01:47 GMT by classifier